Kyto Technology and Life... (CE) Aktie - KBPH

Professionelle Tools für Privatanleger.

Premium

Current Price

1,00

Gebot

0,00

Fragen

0,00

Volumen

0,00 Tagesbereich 0,00

1,00 52-Wochen-Bereich 1,00

Handelsende

1,00

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Kyto Biopharma Inc. Weighs Strategic Options

TORONTO, March 22, 2011 (GLOBE NEWSWIRE) -- Kyto Biopharma Inc. (Pink Sheets:KBPH) ("Kyto") is a Florida-based development stage...

Kyto Biopharma Inc. Announces Participation in Targeted Payload Therapeutics Inc.

Kyto Biopharma Inc. (OTCBB: KBPH), is a Florida biotechnology company focused on developing monoclonal antibody and...

Kyto Biopharma Inc. Announces Licensing Agreement With The Research Foundation of the State University of New York (RFSUNY)

Kyto Biopharma Inc. (“Kyto”), (OTCBB: KBPH), is pleased to announce that it has signed a licensing agreement with the Research...

Kyto Biopharma Inc. Announces High-Affinity Monoclonal Antibody to the Cellular Receptor for Transcobalamin (Vitamin B12)

Kyto Biopharma Inc. (OTCBB: KBPH), is a biotechnology company focused on developing monoclonal antibody and oligonucleotide...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	1	1	1	0	0	CS
12	0	0	1	1	1	0	0	CS
26	0	0	1	1	1	0	0	CS
52	0	0	1	1	1	0	0	CS
156	-1	-50	2	2	1	33	1.3943662	CS
260	-1.25	-55.5555555556	2.25	2.45	1	81	1.89834816	CS

KBPH - Frequently Asked Questions (FAQ)

What is the current Kyto Technology and Life... (CE) share price?

The current share price of Kyto Technology and Life... (CE) is US$ 1,00

What is the 1 year trading range for Kyto Technology and Life... (CE) share price?

Kyto Technology and Life... (CE) has traded in the range of US$ 1,00 to US$ 1,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
STLBSterling Business Solutions Inc (CE)	US$ 0,0002 (19.900,00%)	100
OGNTOrgana Technologies Group Inc (CE)	US$ 0,000167 (16.600,00%)	120
NWTTNW Tech Capital Inc (PK)	US$ 0,0001 (9.900,00%)	22,22k
IMTLImage Protect Inc (PK)	US$ 0,0001 (9.900,00%)	1M
VRAYQViewRay Inc (CE)	US$ 0,0001 (9.900,00%)	664
PHRZFPharol SGPA SA (PK)	US$ 0,0001 (-99,75%)	800
VIEWFViewtran Group Inc (CE)	US$ 0,000001 (-99,00%)	500
TTCFQTattooed Chef Inc (CE)	US$ 0,000001 (-99,00%)	1,55k
TMGIMarquie Group Inc (PK)	US$ 0,000001 (-99,00%)	700k
DLOCDigital Locations Inc (CE)	US$ 0,000001 (-99,00%)	1,56k
TWOHTwo Hands Corporation (PK)	US$ 0,0009 (-35,71%)	179,8M
HMBLHUMBL Inc (PK)	US$ 0,0003 (0,00%)	123,42M
MWWCMarketing Worldwide Corporation (PK)	US$ 0,0001 (0,00%)	103,09M
MJLBUltrack Systems Inc (PK)	US$ 0,0002 (0,00%)	99,23M
ABQQAB International Group Corporation (PK)	US$ 0,0002 (0,00%)	93,28M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Kyto Technology and Life Science Inc (CE) (KBPH)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

KBPH Neueste Nachrichten

Kyto Biopharma Inc. Weighs Strategic Options

Kyto Biopharma Inc. Announces Participation in Targeted Payload Therapeutics Inc.

Kyto Biopharma Inc. Announces Licensing Agreement With The Research Foundation of the State University of New York (RFSUNY)

Kyto Biopharma Inc. Announces High-Affinity Monoclonal Antibody to the Cellular Receptor for Transcobalamin (Vitamin B12)

KBPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Kyto Technology and Life Science Inc (CE) (KBPH) Börsenkurse

Kyto Technology and Life Science Inc (CE) (KBPH)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

KBPH Neueste Nachrichten

Kyto Biopharma Inc. Weighs Strategic Options

Kyto Biopharma Inc. Announces Participation in Targeted Payload Therapeutics Inc.

Kyto Biopharma Inc. Announces Licensing Agreement With The Research Foundation of the State University of New York (RFSUNY)

Kyto Biopharma Inc. Announces High-Affinity Monoclonal Antibody to the Cellular Receptor for Transcobalamin (Vitamin B12)

KBPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen